A vaccine designed to treat Alzheimer’s disease reduced memory impairment in lab mice, according to a study in the Journal of Alzheimer's Disease. The research showed that mouse models with Alzheimer's disease that were given the novel E22W42 DC vaccination containing modified amyloid-beta-sensitized dendritic cells had similar memory performance as non-transgenic controls and had significantly reduced working memory errors and higher brain and blood anti-amyloid-beta antibody levels, compared with those that were given dendritic cells without the amyloid-beta peptide.
Alzheimer's vaccine reduces memory impairment in mice
Sign up for SNMMI SmartBrief
Nuclear medicine and molecular imaging news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.